CoChat

MOLI: multi-omics late integration with deep neural networks for drug response prediction

Open access

Published version of a preprint

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

Motivation: Historically, gene expression has been shown to be the most informative data for drug response prediction. Recent evidence suggests that integrating additional omics can improve the prediction accuracy which raises the question of how to integrate the additional omics. Regardless of the integration strategy, clinical utility and translatability are crucial. Thus, we reasoned a multi-omics approach combined with clinical datasets would improve drug response prediction and clinical relevance. Results: We propose MOLI, a multi-omics late integration method based on deep neural networks. MOLI takes somatic mutation, copy number aberration and gene expression data as input, and integrates them for drug response prediction. MOLI uses type-specific encoding sub-networks to learn features for each omics type, concatenates them into one representation and optimizes this representation via a combined cost function consisting of a triplet loss and a binary cross-entropy loss. The former makes the representations of responder samples more similar to each other and different from the non-responders, and the latter makes this representation predictive of the response values. We validate MOLI on in vitro and in vivo datasets for five chemotherapy agents and two targeted therapeutics. Compared to state-of-the-art single-omics and early integration multi-omics methods, MOLI achieves higher prediction accuracy in external validations. Moreover, a significant improvement in MOLI’s performance is observed for targeted drugs when training on a pan-drug input, i.e. using all the drugs with the same target compared to training only on drug-specific inputs. MOLI’s high predictive power suggests it may have utility in precision oncology. Availability and implementation: https://github.com/hosseinshn/MOLI. Supplementary information: Supplementary data are available at Bioinformatics online.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btz318

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Schematic overview of MOLI (A) pre-processing mutation, CNA and gene expression data. (B) Each encoding sub-network learns features for its omics data type and the learned features are concatenated into one representation. (C) MOLI cost function consists of a triplet loss and a classification loss, obtained from the classifier sub-network that uses the multi-omics representation to predict drug response
Fig. 1. Schematic overview of MOLI (A) pre-processing mutation, CNA and gene expression data. (B) Each encoding sub-network learns features for its omics data type and the learned features are concatenated into one representation. (C) MOLI cost function consists of a triplet loss and a classification loss, obtained from the classifier sub-network that uses the multi-omics representation to predict drug responseCC BY-NC · PubMed Central
Fig. 2. (A) Using MOLI to make predictions for PDX/patient inputs during external validation. (B) Combining targeted drugs that target the same pathway or molecule to make a pan-drug training dataset for MOLI
Fig. 2. (A) Using MOLI to make predictions for PDX/patient inputs during external validation. (B) Combining targeted drugs that target the same pathway or molecule to make a pan-drug training dataset for MOLICC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Khakabimamaghani, 2016, CC BY: PSB 2016 proceedings are published as Open Access chapters by World Scientific Publishing Company and distributed under the terms of the Creative Commons Attribution (CC BY) 4.0 License, 345

Cited by

See all 488

Metadata

Authors
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M.
Affiliations
  • Simon Fraser University (CA)
  • Bielefeld University (DE)
  • University of British Columbia (CA)
Corresponding author
  • Collins, Colin C
  • Ester, Martin
Venue
Bioinformatics
Published
2019-07
Volume
35
Issue
14
Pages
i501-i509
ISSN
  • 1367-4803 (ISSN-L)
  • 1367-4811
OpenAlex
W2955502047
Cited by
421
References
49
Citations by year
2026: 60 · 2025: 71 · 2024: 85 · 2023: 58 · 2022: 58 · 2021: 58 · 2020: 26 · 2019: 5
FWCI
25.12
Type
journal article
Language
en
Open access
Locations
  • Bioinformatics (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
Funders
  • Canada Foundation for Innovation (33440)
  • The Canadian Institutes of Health Research (PJT-153073)
  • Terry Fox Foundation (201012TFF)
  • National Science and Engineering Research Council of Canada (R611347)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
drug response prediction, multi-omics integration, somatic mutations, copy number alterations, gene expression, deep neural network, triplet loss, precision oncology, chemotherapy, targeted therapy
MeSH terms
Algorithms, Antineoplastic Agents, Pharmaceutical Preparations, Forecasting, Humans, Neoplasms, Neural Networks, Computer, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MOLI: multi-omics late integration with deep neural networks for drug response prediction. https://app.cochat.ai/papers/10.1093/bioinformatics/btz318
The paper
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019). MOLI: multi-omics late integration with deep neural networks for drug response prediction. Bioinformatics. https://doi.org/10.1093/bioinformatics/btz318

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.